Compare EHang Holdings Ltd - ADR (EH) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs McKesson Corporation — how do they compare? EHang Holdings Ltd - ADR trades at $5.85 (market cap $437.63M), while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 240.2× EHang Holdings Ltd - ADR's market cap, and McKesson Corporation pays a 0.42% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| EH | MCK | |
|---|---|---|
Market Cap | $437.63M | $105.14B |
Sector | Industrials | Health |
52-Week High | $19.44 | $995.69 |
52-Week Low | $4.90 | $659.01 |
Enterprise Value | $376.84M | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
